David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Lithia Motors
LAD
$8.14B
| $1.9M | ﹤0.01% |
19,107
+5,028
| +36% | +$452K |
|
2027
MACOM Technology Solutions
MTSI
$20.8B
| $1.89M | ﹤0.01% |
50,777
-15,314
| -23% | -$512K |
|
|
SSRI
2028
DELISTED
Silver Standard Resources
SSRI
| $1.89M | ﹤0.01% |
417,656
-935,163
| -69% | -$5.19M |
|
2029
Immunic
IMUX
$225M
| $1.89M | ﹤0.01% |
189
+45
| +31% | +$414K |
|
|
CBB
2030
DELISTED
Cincinnati Bell Inc.
CBB
| $1.89M | ﹤0.01% |
107,167
+16,573
| +18% | +$274K |
|
2031
PUT
Analog Devices
ADI
$180B
| $1.89M | ﹤0.01% |
30,000
-161,700
| -84% | -$9.17M |
|
|
ARIA
2032
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.89M | ﹤0.01% |
229,333
-136,195
| -37% | -$1.01M |
|
|
DENN
2033
DELISTED
Denny's
DENN
| $1.89M | ﹤0.01% |
165,627
-223,981
| -57% | -$2.5M |
|
|
LVLT
2034
CALL
DELISTED
Level 3 Communications Inc
LVLT
| $1.88M | ﹤0.01% |
35,000
-9,800
| -22% | -$511K |
|
2035
Fair Isaac
FICO
$24.5B
| $1.88M | ﹤0.01% |
21,191
-123,898
| -85% | -$9.97M |
|
2036
CALL
Baxter International
BAX
$13.7B
| $1.88M | ﹤0.01% |
50,443
-368,200
| -88% | -$14M |
|
|
TA
2037
DELISTED
TravelCenters of America LLC
TA
| $1.88M | ﹤0.01% |
21,519
+14,157
| +192% | +$996K |
|
|
TRQ
2038
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $1.88M | ﹤0.01% |
60,140
+57,121
| +1,892% | +$1.72M |
|
2039
Harmonic Inc
HLIT
$1.36B
| $1.87M | ﹤0.01% |
252,936
+56,603
| +29% | +$420K |
|
|
GAU
2040
Galiano Gold
GAU
$620M
| $1.87M | ﹤0.01% |
1,317,538
-96,200
| -7% | -$148K |
|
2041
CALL
First Solar
FSLR
$22.1B
| $1.87M | ﹤0.01% |
31,300
-34,700
| -53% | -$1.78M |
|
2042
Leggett & Platt
LEG
$1.26B
| $1.87M | ﹤0.01% |
+40,578
| New | +$1.81M |
|
|
CDK
2043
CALL
DELISTED
CDK Global, Inc.
CDK
| $1.87M | ﹤0.01% |
+40,000
| New | +$1.82M |
|
|
SDRL
2044
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
| $1.87M | ﹤0.01% |
747
+672
| +896% | +$1.95M |
|
2045
Brinker International
EAT
$10.3B
| $1.87M | ﹤0.01% |
+30,364
| New | +$1.83M |
|
2046
PUT
Constellium
CSTM
$3.68B
| $1.86M | ﹤0.01% |
91,500
| – | – |
|
2047
PUT
Ionis Pharmaceuticals
IONS
$10.5B
| $1.86M | ﹤0.01% |
29,200
-8,400
| -22% | -$570K |
|
|
ACI
2048
DELISTED
ARCH COAL, INC.
ACI
| $1.85M | ﹤0.01% |
185,265
-8,261
| -4% | -$95.8K |
|
2049
PUT
Agnico Eagle Mines
AEM
$108B
| $1.85M | ﹤0.01% |
66,200
-234,800
| -78% | -$7.22M |
|
2050
PUT
Abbott
ABT
$197B
| $1.85M | ﹤0.01% |
39,900
-484,400
| -92% | -$22.2M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.